Alphabet, the parent company of Google, has invested cash in a UK startup that spun out of the Oxford University. The startup is said to be working on developing a vaccine for flu.
The tech giant is backing the startup called Vaccitech through GV, the company’s venture arm that is formerly known as Google Ventures, along with Sequoia Capital, a prominent Silicon Valley investor which has previously backed WhatsApp, Uber, and Snap.
Also investing in the said startup to the tune of £20m is Oxford Sciences Innovation, an incubator that is set up to commercialise research from the university and which is also backed by Google and other investors including Charles Dunstone, the Carphone Warehouse founder, and a fund that is run by Neil Woodford.
Vaccitech is involved in clinical testing for a flu vaccine that is said work on all types of the influenza A virus. The company is also working on a vaccine for Prostate Cancer and some other diseases.